Dosing Oncology Therapeutics in Combination Therapy for Renal Dysfunction: The University of California San Diego Study of Personalized Cancer Therapy to Determine Response and Toxicity (UCSD-PREDICT) Experience

Introduction Dose reductions are often required to avoid toxicity in combination therapy for advanced cancers, but information on appropriate dose reductions in renal dysfunction is lacking. This study assessed dose reductions of renally cleared oncology agents given in combination therapy in the se...

Full description

Saved in:
Bibliographic Details
Published in:Cureus
Main Authors: Nikanjam, Mina, Wing, Jason, Capparelli, Edmund, Kurzrock, Razelle
Format: Artigo
Language:Inglês
Published: Cureus 2018
Subjects:
Nephrology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6349570/
https://ncbi.nlm.nih.gov/pubmed/30705793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.3634
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items